Finance

Senarai
Tinjauan: 71.9% bulis·0.0% bearis
Akses analisis
LH:NYSE
Labcorp Holdings Inc
USD 362.36
-1.47%
(-5.39) 1H
5 Nov, 2:47:12 PTG GMT-5  ·   USD
Semua simbol
SimbolHargaPerubahan% Perubahan
Menjana cerapan popular untuk LH...
Buka
USD 372.55
Tinggi
USD 373.34
Rendah
USD 359.62
Permodalan Pasaran
29.42B
Purata volum
741.63K
Volum
350.48K
Dividen
0.79%
Dividen suku tahunan
USD 0.72
Tarikh tanpa dividen
29 Mei 2026
Nisbah H/P
29.72
tgi 52 mgu
USD 373.34
rdh 52 mgu
USD 244.52
EPS
USD 12.19
Beta
0.87
Syer tertunggak
81.20J
Bilangan pekerja
71K
Buka
USD 372.55
Tinggi
USD 373.34
Rendah
USD 359.62
Permodalan Pasaran
29.42B
Purata volum
741.63K
Volum
350.48K
Dividen
0.79%
Dividen suku tahunan
USD 0.72
Tarikh tanpa dividen
29 Mei 2026
Nisbah H/P
29.72
tgi 52 mgu
USD 373.34
rdh 52 mgu
USD 244.52
EPS
USD 12.19
Beta
0.87
Syer tertunggak
81.20J
Bilangan pekerja
71K
Cerita berita
Daripada sumber web dan rakan kongsi berita
Profil
Labcorp Holdings Inc., operating under the brand name Labcorp, headquartered in Burlington, North Carolina, provides laboratory services used for diagnosis and healthcare decisions. It operates one of the largest clinical laboratory networks in the world and has operations in over 100 countries; although its operations are primarily in the U.S. Its Diagnostics Laboratories segment operates 2,000 patient service centers with more than 6,000 in-office phlebotomists in the United States. In addition to healthcare testing such as oncology testing, human immunodeficiency virus genotyping and phenotyping, it provides testing for: employment, DNA testing to determine parentage and to determine immigration eligibility, environmental issues, wellness, toxicology, pain management, and medical drug monitoring. It also provides 50 tests that patients can complete at home. It processes over 160 million tests per year. Approximately 10% of this segment’s revenue are from the U.S. Medicare health insurance program. Wikipedia
Perihal Labcorp Holdings Inc
CEOAdam H. Schechter
Pekerja71K
Diasaskan1978
Ibu pejabatBurlington, Carolina Utara, Amerika Syarikat
SektorHealth Care
Industri-
Laman weblabcorp.com
Rating penganalisis
Berdasarkan 14 penganalisis yang memberikan rating saham kepada LH dalam tempoh 3 bulan yang lalu
Belian kuat
Beli
11
Pegang
3
Jual
0
Ramalan 12 bulan
Berdasarkan 14 penganalisis Wall Street yang menawarkan sasaran harga 12 bulan untuk LH dalam tempoh 3 bulan yang lalu.
Tertinggi
Semasa USD 362.36
USD 420.00 (+15.91%)
Purata
USD 387.18 (+6.85%)
Terendah
USD 340.00 (-6.17%)
Penganalisis
Syor
Tindakan
Sasaran harga
Diunjurkan
Tarikh
Unknown Analyst
HSBC
Buy
Upgraded
USD 410.00
+13.1%
11/05/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
USD 400.00
+10.4%
11/04/2026
David Westenberg
Piper Sandler
Hold
Maintained
USD 365.00
+0.7%
10/30/2026
David S Macdonald
Truist Financial
Buy
Maintained
USD 395.00
+9%
10/29/2026
Lu Li
Bank of America Securities
Buy
Reiterated
-
-
10/29/2026
Pito Chickering
Deutsche Bank
Hold
Maintained
USD 355.00
-2%
10/29/2026
Kevin Caliendo
UBS
Buy
Reiterated
USD 420.00
+15.9%
10/29/2026
Erin Wright
Morgan Stanley
Buy
Reiterated
USD 388.00
+7.1%
10/30/2026
Eric Coldwell
Robert W. Baird
Buy
Maintained
USD 396.00
+9.3%
10/29/2026
Luke Sergott
Barclays
Hold
Maintained
USD 380.00
+4.9%
10/28/2026
Michael Cherny
Leerink Partners
Buy
Reiterated
USD 410.00
+13.1%
10/29/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Maintained
USD 340.00
-6.2%
09/11/2026
Jared Haase
William Blair
Buy
Reiterated
-
-
09/11/2026
Lisa Gill
J.P. Morgan
Buy
Maintained
-
-
08/26/2026
Michael Ryskin
Bank of America Securities
Buy
Reiterated
USD 360.00
-0.7%
07/30/2026
David Toung
Argus Research
Buy
Maintained
USD 310.00
-14.4%
06/02/2026
Unknown Analyst
Mizuho Securities
Buy
Reiterated
USD 320.00
-11.7%
05/27/2026
Andrew Brackmann
William Blair
Buy
Maintained
-
-
04/30/2026
Laporan terakhir
28 Okt 2026
Tempoh fiskal
S3 2026
USD 4.78 / USD 4.64
+2.94%melebihi
Hasil / Anggaran (USD)
3.81B / 3.76B
+1.35%melebihi
Panggilan persidangan pendapatan fiskal Suku Ke-3 2026
Menunggu panggilan persidangan pendapatan
Sekilas pandang
Cerapan daripada berita dan laporan terkini
Laporan sebelumnyaSemua nilai dalam USD
Loading Previous Earnings...
Hasil
Pendapatan bersih
Semua nilai dalam USD
Dis 2025
Mac 2026
Jun 2026
Sep 2026
Hasil
3.52B
3.54B
3.73B
3.81B
Kos barangan yang dijual
2.52B
2.52B
2.62B
2.70B
Kos hasil
2.52B
2.52B
2.62B
2.70B
Perbelanjaan penyelidikan dan pembangunan
-
-
-
-
Jumlah perbelanjaan penyelidikan dan pembangunan
-
-
-
-
Perbelanjaan jualan, am dan pentadbiran
549.70J
551.00J
577.20J
611.40J
Belanja kendalian
622.30J
626.60J
655.30J
692.60J
Jumlah belanja kendalian
3.14B
3.15B
3.27B
3.39B
Pendapatan kendalian
370.90J
387.20J
456.70J
415.50J
Pendapatan bukan kendalian lain
1.90J
-600.00K
-3.50J
-5.40J
EBT termasuk item luar biasa
190.60J
319.70J
386.40J
328.00J
EBT tidak termasuk item luar biasa
315.20J
333.20J
391.50J
341.40J
Belanja cukai pendapatan
25.70J
41.70J
87.30J
64.90J
Kadar cukai berkesan
13.48%
13.04%
22.59%
19.79%
Belanja kendalian lain
-
-
-
2.50J
Pendapatan bersih
164.70J
277.80J
298.70J
262.80J
Margin untung bersih
4.68%
7.85%
8.01%
6.90%
Perolehan bagi setiap syer
4.07
4.25
4.99
4.78
Pendapatan faedah dan pelaburan
3.50J
12.20J
5.60J
1.40J
Belanja faedah
-55.00J
-55.10J
-61.10J
-59.10J
Belanja faedah bersih
-51.50J
-42.90J
-55.50J
-57.70J
Caj susut nilai dan pelunasan
-
-
-
-
EBITDA
549.40J
560.50J
635.70J
598.50J
Keuntungan atau kerugian daripada jualan aset
-
-
-
-
Transaksi orang dalam
Data transaksi orang dalam diperoleh daripada sumber pihak ketiga. Ketahui lebih lanjut
Orang dalam
Jawatan
Jenis
Tarikh
Saham
Jumlah
Halaman 1
Acara akan datang
Kandungan AI boleh mengandungi kesilapan. Ketahui lebih lanjut
BantuanHantar maklum balasPrivasiSyaratPenafian
Apl Google